Bay Harbor Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $311K | Buy |
1,237
+546
| +79% | +$117K | 0.07% | 55 |
|
|
2026
Q1 | $150K | Buy |
691
+6
| +0.9% | +$1.33K | 0.04% | 59 |
|
|
2025
Q4 | $157K | Buy |
685
+14
| +2% | +$3.19K | 0.04% | 61 |
|
|
2025
Q3 | $155K | Buy |
671
+17
| +3% | +$3.46K | 0.04% | 59 |
|
|
2025
Q2 | $121K | Buy |
654
+45
| +7% | +$8.36K | 0.04% | 70 |
|
|
2025
Q1 | $128K | Buy |
609
+71
| +13% | +$13.8K | 0.04% | 58 |
|
|
2024
Q4 | $95.6K | Buy |
538
+37
| +7% | +$6.8K | 0.03% | 74 |
|
|
2024
Q3 | $98.9K | Sell |
501
-12
| -2% | -$2.24K | 0.03% | 64 |
|
|
2024
Q2 | $88K | Buy |
513
+16
| +3% | +$2.65K | 0.03% | 70 |
|
|
2024
Q1 | $90.5K | Sell |
497
-4
| -0.8% | -$689 | 0.03% | 72 |
|
|
2023
Q4 | $77.6K | Buy |
501
+2
| +0.4% | +$292 | 0.03% | 77 |
|
|
2023
Q3 | $74.4K | Buy |
499
+6
| +1% | +$881 | 0.03% | 68 |
|
|
2023
Q2 | $66.4K | Sell |
493
-38
| -7% | -$5.57K | 0.03% | 79 |
|
|
2023
Q1 | $84.6K | Sell |
531
-34
| -6% | -$5.2K | 0.04% | 55 |
|
|
2022
Q4 | $91K | Sell |
565
-10
| -2% | -$1.53K | 0.04% | 49 |
|
|
2022
Q3 | $77K | Sell |
575
-20
| -3% | -$2.87K | 0.04% | 57 |
|
|
2022
Q2 | $91K | Hold |
595
| – | – | 0.04% | 52 |
|
|
2022
Q1 | $96K | Sell |
595
-144
| -19% | -$20.9K | 0.04% | 52 |
|
|
2021
Q4 | $105K | Sell |
739
-121
| -14% | -$14.3K | 0.04% | 52 |
|
|
2021
Q3 | $93K | Sell |
860
-132
| -13% | -$15.1K | 0.04% | 64 |
|
|
2021
Q2 | $112K | Sell |
992
-441
| -31% | -$49.7K | 0.05% | 69 |
|
|
2021
Q1 | $155K | Sell |
1,433
-411
| -22% | -$44K | 0.07% | 60 |
|
|
2020
Q4 | $198K | Sell |
1,844
-1,017
| -36% | -$97.7K | 0.09% | 73 |
|
|
2020
Q3 | $251K | Sell |
2,861
-1,319
| -32% | -$124K | 0.13% | 68 |
|
|
2020
Q2 | $410K | Sell |
4,180
-923
| -18% | -$81.3K | 0.22% | 59 |
|
|
2020
Q1 | $389K | Sell |
5,103
-229
| -4% | -$19.5K | 0.24% | 52 |
|
|
2019
Q4 | $472K | Sell |
5,332
-13
| -0.2% | -$1.08K | 0.25% | 52 |
|
|
2019
Q3 | $397K | Buy |
5,345
+558
| +12% | +$38.3K | 0.24% | 56 |
|
|
2019
Q2 | $348K | Sell |
4,787
-105
| -2% | -$8.25K | 0.22% | 68 |
|
|
2019
Q1 | $394K | Buy |
4,892
+743
| +18% | +$60.8K | 0.27% | 62 |
|
|
2018
Q4 | $382K | Buy |
+4,149
| New | +$365K | 0.3% | 57 |
|
Other funds holding ABBV
Bay Harbor Wealth Management's ABBV Position: Q2 2026 in Review
Bay Harbor Wealth Management increased its AbbVie (ABBV) stake by 79% in Q2 2026, buying an estimated $117K and bringing the position to 1,237 shares worth $311K. The position accounts for 0.07% of the portfolio, ranked #55.
Bay Harbor Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $472K in Q4 2019. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Bay Harbor Wealth Management held 1,237 shares of AbbVie worth $311K as of Q2 2026.
- Bay Harbor Wealth Management bought 546 AbbVie shares in Q2 2026, an estimated $117K.
- AbbVie made up 0.07% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #55 holding.
- Bay Harbor Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Bay Harbor Wealth Management's AbbVie position peaked at $472K in Q4 2019.
- 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.